Approval status: Aesthetic Resolution ADR is currently completing its approval/accreditation process. This page will be updated once formal status is granted.

The UK consumer aesthetics sector

Last updated: 7 May 2026

An overview of the UK private medical aesthetic and cosmetic surgery market, the regulatory landscape, and where consumer ADR fits.

Why consumer ADR matters here

UK consumers spend billions of pounds each year on private medical aesthetic and cosmetic surgery services. The sector is large, fragmented and varied — from specialist hospitals to independent practitioners. Most providers deliver good outcomes; a minority of cases give rise to consumer complaints that internal procedures alone cannot resolve fairly.

For these complaints, the courts are slow and expensive, and clinical regulators focus on practitioner conduct, not on resolving the consumer’s underlying contractual or service grievance. Consumer ADR is the route designed to bridge this gap — fair, fast, written, and free for consumers.

Regulatory backdrop

Where AR-ADR sits

AR-ADR is not a regulator. It does not register practitioners, set clinical standards or sanction misconduct. It operates as the independent consumer ADR body for disputes between a consumer and a UK trader about the terms, performance and consequences of a private medical aesthetic or cosmetic surgery service.

We complement, rather than substitute for:

Why a sector-specific scheme

Generalist consumer ADR providers handle many sectors. A scheme purpose-built for medical aesthetics adds value because:

Working with others

AR-ADR will share anonymised, aggregated insight with regulators, voluntary registers and policymakers where doing so supports consumer protection. We will signpost consumers to other routes — including small claims, regulators or registers — when AR-ADR is not the right mechanism for their issue. We will not act as a backdoor to professional regulation: practitioner conduct issues are for professional regulators.

Related